English label_2 (Q9935): Difference between revisions
Jump to navigation
Jump to search
(Removed claims) |
(Changed an Item) |
||||||||||||||
| Property / EU contribution | |||||||||||||||
7,500,000.0 Czech koruna
| |||||||||||||||
| Property / EU contribution: 7,500,000.0 Czech koruna / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / EU contribution | |||||||||||||||
300,000.0 Euro
| |||||||||||||||
| Property / EU contribution: 300,000.0 Euro / rank | |||||||||||||||
Preferred rank | |||||||||||||||
| Property / EU contribution: 300,000.0 Euro / qualifier | |||||||||||||||
exchange rate to Euro: 0.04 Euro
| |||||||||||||||
| Property / EU contribution: 300,000.0 Euro / qualifier | |||||||||||||||
point in time: 10 January 2020
| |||||||||||||||
| Property / budget | |||||||||||||||
30,000,000.0 Czech koruna
| |||||||||||||||
| Property / budget: 30,000,000.0 Czech koruna / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / budget | |||||||||||||||
1,200,000.0 Euro
| |||||||||||||||
| Property / budget: 1,200,000.0 Euro / rank | |||||||||||||||
Preferred rank | |||||||||||||||
| Property / budget: 1,200,000.0 Euro / qualifier | |||||||||||||||
exchange rate to Euro: 0.04 Euro
| |||||||||||||||
| Property / budget: 1,200,000.0 Euro / qualifier | |||||||||||||||
point in time: 10 January 2020
| |||||||||||||||
Revision as of 16:22, 11 February 2020
Project in Czech Republic financed by DG Regio
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | English label_2 |
Project in Czech Republic financed by DG Regio |
Statements
7,500,000.0 Czech koruna
0 references
30,000,000.0 Czech koruna
0 references
25 percent
0 references
19 November 2015
0 references
23 August 2018
0 references
1 October 2018
0 references
Bioveta, a.s.
0 references
49°18'9.65"N, 17°4'54.52"E
0 references
49°17'53.88"N, 17°6'21.31"E
0 references
68323
0 references
Předmětem projektu je inovace procesu výroby a kultivace vakcín proti leptospiróze a borelióze založená na pomnožení spirochet fermentační kultivací v průmyslovém bioreaktoru. Inovace procesu bude realizována formou zavedení nové technologie výroby antigenů. Inovace se týká celé řady přípravků (např. Biocan L, Biocan Novel L4, B BioBos L, BioBos L6, Biofel B, Biocan B, Borrelym). V rámci projektu bude pořízena technologie pro nový způsob výroby, a to bioreaktory, formulační kotel a ultrafiltr. a. (Czech)
0 references
Identifiers
CZ.01.1.02/0.0/0.0/15_014/0004382
0 references